Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash provided by (used for) operating activities
Cash provided by (used for) operating activities	$ 1,144	$ 291
Investing activities:
Purchases of property, plant and equipment	(275)	(210)
Proceeds from sale of property, plant and equipment	5	0
Payments for acquisitions of businesses, net of cash acquired	(4,382)	(968)
Payments for investments and acquisitions of certain technologies	(137)	(148)
Proceeds from divestiture of certain businesses	90	0
Payments for settlements of hedge contracts	(294)	0
Cash provided by (used for) investing activities	(4,992)	(1,326)
Financing activities:
Payment of contingent consideration amounts and royalty rights previously established in purchase accounting	(135)	(16)
Payments on short-term borrowings	(1,000)	0
Proceeds from short-term borrowings, net of debt issuance costs	0	999
Net increase (decrease) in commercial paper	13	(403)
Payments on borrowings from credit facilities	0	(569)
Proceeds from borrowings on credit facilities	0	569
Payments on long-term borrowings and debt extinguishment costs	(1,472)	(602)
Proceeds from long-term borrowings, net of debt issuance costs	6,243	989
Cash used to net share settle employee equity awards	(64)	(54)
Proceeds from issuances of shares of common stock	113	94
Cash provided by (used for) financing activities	3,697	1,007
Effect of foreign exchange rates on cash	(2)	(9)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	(153)	(37)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	829	1,017
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	676	980
Supplemental Information
Stock-based compensation expense	116	104
Fair value of contingent consideration recorded in purchase accounting	$ 127	$ 190